India, Sept. 17 -- Innate Pharma SA (IPH) announced Loss for first half of -EUR19.62 million
The company's bottom line came in at -EUR19.62 million, or -EUR0.21 per share. This compares with -EUR21.34 million, or -EUR0.25 per share, last year.
The company's revenue for the period rose 16.5% to EUR5.66 million from EUR4.86 million last year.
Innate Pharma SA earnings at a glance (GAAP) :
-Earnings: -EUR19.62 Mln. vs. -EUR21.34 Mln. last year.-EPS: -EUR0.21 vs. -EUR0.25 last year.-Revenue: EUR5.66 Mln vs. EUR4.86 Mln last year.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....